Shares of Waldencast plc (NASDAQ:WALD - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $5.40.
Several analysts recently issued reports on WALD shares. Telsey Advisory Group set a $5.00 price objective on shares of Waldencast in a research note on Thursday, March 20th. DA Davidson restated a "buy" rating and issued a $7.50 price target on shares of Waldencast in a research report on Wednesday, March 19th. Industrial Alliance Securities set a $5.00 price target on Waldencast in a report on Tuesday, April 22nd. Finally, Alliance Global Partners started coverage on Waldencast in a research note on Tuesday, April 22nd. They set a "buy" rating and a $5.00 price objective on the stock.
Read Our Latest Research Report on WALD
Institutional Trading of Waldencast
Institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC purchased a new position in Waldencast in the fourth quarter worth approximately $42,000. Stonebrook Private Inc. acquired a new position in shares of Waldencast in the 4th quarter valued at $48,000. Ethic Inc. purchased a new position in shares of Waldencast during the 4th quarter worth $56,000. Wells Fargo & Company MN increased its position in shares of Waldencast by 29.9% during the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock worth $59,000 after purchasing an additional 3,358 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Waldencast in the 4th quarter valued at about $70,000. Hedge funds and other institutional investors own 41.97% of the company's stock.
Waldencast Trading Down 4.6 %
Shares of Waldencast stock traded down $0.13 during trading hours on Tuesday, reaching $2.69. 42,958 shares of the company's stock were exchanged, compared to its average volume of 127,362. The business has a fifty day moving average of $2.94 and a two-hundred day moving average of $3.26. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78. Waldencast has a 1 year low of $2.31 and a 1 year high of $5.46.
Waldencast Company Profile
(
Get Free ReportWaldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
See Also
Before you consider Waldencast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waldencast wasn't on the list.
While Waldencast currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
